Europe in Action: Commission seeks ban on milk drug
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A GENETICALLY engineered drug that increases a cow's milk yield should be banned from Europe for at least seven years, according to a recommendation by the European Commission.
The decision sets a vitally important precedent for the acceptance of all biotechnology products in Europe. If it is ratified by the Council of Agriculture Ministers in September, the ban will end commercial prospects for the drug, Bovine Somatotropin (BST), which is the first genetically engineered product other than human drugs to come on to the market.
Decisions on new products have, until now, been limited to a technical assessment of safety, quality and efficacy but the commission has taken broader social and economic factors into account over BST.
The commission has effectively ruled that this new product is not needed, rather than letting market forces decide.
The commission's decision was greeted with dismay by the biotechnology industry. Brian Ager, from the Brussels-based Senior Advisory Group for Biotechnology, said: 'If Europe cannot assimilate new technology like the rest of the world then we will suffer in terms of our fundamental technologies, such as agriculture, the chemical industry and the pharmaceutical industry - that will damage employment prospects throughout the EC. If this sort of uncertainty exists, companies are not going to make the investment in new technologies.'
But environmentalists hailed it as a victory. 'BST is a product nobody wants but the manufacturers,' Steve Emmott, of the British Genetics Forum, said. Fears that its use would drive small dairy farmers bankrupt, favouring only large-scale intensive farms run by big business, lay behind the commission's decision.
The commission also noted that, although many consumers were strongly opposed to the introduction of BST, it was impossible to label items to allow them to choose non- BST milk products.
It also felt that safeguards to protect the health of cows could not be properly enforced or controlled under field conditions.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments